BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

629 related articles for article (PubMed ID: 34208829)

  • 1. Ex Vivo Activation of Red Blood Cell Senescence by Plasma from Sickle-Cell Disease Patients: Correlation between Markers and Adhesion Consequences during Acute Disease Events.
    Chadebech P; Bodivit G; Di Liberto G; Jouard A; Vasseur C; Pirenne F; Bartolucci P
    Biomolecules; 2021 Jun; 11(7):. PubMed ID: 34208829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence of benefits from using fresh and cryopreserved blood to transfuse patients with acute sickle cell disease.
    Chadebech P; de Ménorval MA; Bodivit G; Mekontso-Dessap A; Pakdaman S; Jouard A; Galactéros F; Bierling P; Habibi A; Pirenne F
    Transfusion; 2016 Jul; 56(7):1730-8. PubMed ID: 27184475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of red blood cell (RBC) transfusion on sickle cell disease recipient plasma and RBC metabolism.
    Culp-Hill R; Srinivasan AJ; Gehrke S; Kamyszek R; Ansari A; Shah N; Welsby I; D'Alessandro A
    Transfusion; 2018 Dec; 58(12):2797-2806. PubMed ID: 30265764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombin generation and cell-dependent hypercoagulability in sickle cell disease.
    Whelihan MF; Lim MY; Mooberry MJ; Piegore MG; Ilich A; Wogu A; Cai J; Monroe DM; Ataga KI; Mann KG; Key NS
    J Thromb Haemost; 2016 Oct; 14(10):1941-1952. PubMed ID: 27430959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mathematical calculation of lifespan of transfused RBCs in sickle cell disease patients.
    Kim J; Usmani A; De Simone N; Sarode R
    Transfus Apher Sci; 2018 Feb; 57(1):46-49. PubMed ID: 29196100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoxic storage of donor red cells preserves deformability after exposure to plasma from adults with sickle cell disease.
    Karafin MS; Field JJ; Ilich A; Li L; Qaquish BF; Shevkoplyas SS; Yoshida T
    Transfusion; 2023 Jan; 63(1):193-202. PubMed ID: 36310401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival of transfused red blood cells from a donor with alpha-thalassemia trait in a recipient with sickle cell disease.
    Yee MEM; Covington ML; Zerra PE; McCoy JW; Easley KA; Joiner CH; Bryksin J; Francis RO; Lough CM; Patel N; Kutlar A; Josephson CD; Roback JD; Stowell SR; Fasano RM
    Transfusion; 2024 Jun; 64(6):1109-1115. PubMed ID: 38693059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delayed hemolytic transfusion reaction/hyperhemolysis syndrome in children with sickle cell disease.
    Talano JA; Hillery CA; Gottschall JL; Baylerian DM; Scott JP
    Pediatrics; 2003 Jun; 111(6 Pt 1):e661-5. PubMed ID: 12777582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of Active ICAM-4 on Normal and Sickle Cell Disease RBCs via AKAPs Is Revealed by AFM.
    Zhang J; Abiraman K; Jones SM; Lykotrafitis G; Andemariam B
    Biophys J; 2017 Jan; 112(1):143-152. PubMed ID: 28076805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Red blood cell mechanical sensitivity improves in patients with sickle cell disease undergoing chronic transfusion after prolonged, subhemolytic shear exposure.
    Simmonds MJ; Suriany S; Ponce D; Detterich JA
    Transfusion; 2018 Dec; 58(12):2788-2796. PubMed ID: 30325033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythrocyte adhesion is modified by alterations in cellular tonicity and volume.
    Wandersee NJ; Punzalan RC; Rettig MP; Kennedy MD; Pajewski NM; Sabina RL; Paul Scott J; Low PS; Hillery CA
    Br J Haematol; 2005 Nov; 131(3):366-77. PubMed ID: 16225657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Red blood cell adhesion to ICAM-1 is mediated by fibrinogen and is associated with right-to-left shunts in sickle cell disease.
    Kucukal E; Man Y; Quinn E; Tewari N; An R; Ilich A; Key NS; Little JA; Gurkan UA
    Blood Adv; 2020 Aug; 4(15):3688-3698. PubMed ID: 32777069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. More efficient exchange of sickle red blood cells can be achieved by exchanging the densest red blood cells: An ex vivo proof of concept study.
    Thibodeaux SR; Tanhehco YC; Irwin L; Jamensky L; Schell K; O'Doherty U
    Transfus Apher Sci; 2019 Feb; 58(1):100-106. PubMed ID: 30616959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delayed hemolytic transfusion reaction in sickle cell disease patients: evidence of an emerging syndrome with suicidal red blood cell death.
    Chadebech P; Habibi A; Nzouakou R; Bachir D; Meunier-Costes N; Bonin P; Rodet M; Chami B; Galacteros F; Bierling P; Noizat-Pirenne F
    Transfusion; 2009 Sep; 49(9):1785-92. PubMed ID: 19413729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of repleting organic phosphates in banked erythrocytes on plasma metabolites and vasoactive mediators after red cell exchange transfusion in sickle cell disease.
    Lopez Domowicz DA; Welsby I; Esther CR; Zhu H; Marek RD; Lee G; Shah N; Poisson JL; McMahon TJ
    Blood Transfus; 2020 May; 18(3):200-207. PubMed ID: 32203007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo evaluation of the effect of sickle cell hemoglobin S, C and therapeutic transfusion on erythrocyte metabolism and cardiorenal dysfunction.
    D'Alessandro A; Nouraie SM; Zhang Y; Cendali F; Gamboni F; Reisz JA; Zhang X; Bartsch KW; Galbraith MD; Gordeuk VR; Gladwin MT
    Am J Hematol; 2023 Jul; 98(7):1017-1028. PubMed ID: 36971592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sickle red blood cell-derived extracellular vesicles activate endothelial cells and enhance sickle red cell adhesion mediated by von Willebrand factor.
    An R; Man Y; Cheng K; Zhang T; Chen C; Wang F; Abdulla F; Kucukal E; Wulftange WJ; Goreke U; Bode A; Nayak LV; Vercellotti GM; Belcher JD; Little JA; Gurkan UA
    Br J Haematol; 2023 May; 201(3):552-563. PubMed ID: 36604837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigen matching for transfusion support in Brazilian female patients with sickle cell disease to reduce RBC alloimmunization.
    Muniz JG; Arnoni C; Medeiros R; Vendrame T; Cortez A; S Afonso J; Latini F; Castilho L; Girão M
    Transfusion; 2021 Aug; 61(8):2458-2467. PubMed ID: 34121200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythrocyte plasma membrane-bound ERK1/2 activation promotes ICAM-4-mediated sickle red cell adhesion to endothelium.
    Zennadi R; Whalen EJ; Soderblom EJ; Alexander SC; Thompson JW; Dubois LG; Moseley MA; Telen MJ
    Blood; 2012 Feb; 119(5):1217-27. PubMed ID: 22147898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Piezo1 activation augments sickling propensity and the adhesive properties of sickle red blood cells in a calcium-dependent manner.
    Nader E; Conran N; Leonardo FC; Hatem A; Boisson C; Carin R; Renoux C; Costa FF; Joly P; Brito PL; Esperti S; Bernard J; Gauthier A; Poutrel S; Bertrand Y; Garcia C; Saad STO; Egée S; Connes P
    Br J Haematol; 2023 Aug; 202(3):657-668. PubMed ID: 37011913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.